Search Results

Filter
  • 1-10 of  12,010 results for ""INSULIN resistance""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Twenty-four-hour physical behaviour profiles across type 2 diabetes mellitus subtypes.

  • Authors : Henson J; Diabetes Research Centre, College of Life Sciences, University of Leicester, Leicester, UK.; Tziannou A

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Insulin Resistance*

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Apr; Vol. 26 (4), pp. 1355-1365. Date of Electronic Publication: 2024 Jan 08.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Evaluation of the relationship of cytokines concentrations tumor necrosis factor-alpha, interleukin-6, and C-reactive protein in obese diabetics and obese non-diabetics: A comparative study.

Subjects: Insulin Resistance* ; Diabetes Mellitus*; Adult

  • Source: Biotechnology and applied biochemistry [Biotechnol Appl Biochem] 2024 Apr; Vol. 71 (2), pp. 272-279. Date of Electronic Publication: 2023 Dec 06.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8609465 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Blood Pressure Partially Mediated the Association of Insulin Resistance and Cerebral Small Vessel Disease: A Community-Based Study.

  • Authors : Zhou M; Department of Neurology Beijing Tiantan Hospital, Capital Medical University Beijing China.; China National Clinical Research Center for Neurological Diseases Beijing China.

Subjects: Cerebral Small Vessel Diseases*/Cerebral Small Vessel Diseases*/Cerebral Small Vessel Diseases*/diagnostic imaging ; Cerebral Small Vessel Diseases*/Cerebral Small Vessel Diseases*/Cerebral Small Vessel Diseases*/epidemiology ; Hypertension*/Hypertension*/Hypertension*/diagnosis

  • Source: Journal of the American Heart Association [J Am Heart Assoc] 2024 Mar 05; Vol. 13 (5), pp. e031723. Date of Electronic Publication: 2024 Feb 23.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Mitochondrial damage-associated molecular patterns: A new insight into metabolic inflammation in type 2 diabetes mellitus.

  • Authors : Wang Y; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.; Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Insulin Resistance*; Humans

  • Source: Diabetes/metabolism research and reviews [Diabetes Metab Res Rev] 2024 Feb; Vol. 40 (2), pp. e3733. Date of Electronic Publication: 2023 Oct 12.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883450 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Capsiate ameliorates secondary hyperparathyroidism by improving insulin sensitivity and inhibiting angiogenesis.

  • Authors : Li P; Department of Plastic Surgery, The Third Xiangya Hospital, Central South University, Changsha, China.; Zhou J

Subjects: Insulin Resistance* ; Hyperparathyroidism, Secondary*/Hyperparathyroidism, Secondary*/Hyperparathyroidism, Secondary*/drug therapy ; Hyperparathyroidism, Secondary*/Hyperparathyroidism, Secondary*/Hyperparathyroidism, Secondary*/etiology

  • Source: Journal of cellular and molecular medicine [J Cell Mol Med] 2024 Apr; Vol. 28 (8), pp. e18202.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Neurological and metabolic related pathophysiologies and treatment of comorbid diabetes with depression.

  • Authors : Li S; Department of Psychiatry, The School of Clinical Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.; Department of Psychiatry, Brain Hospital of Hunan Province (The Second People's Hospital of Hunan Province), Changsha, Hunan, China.

Subjects: Insulin Resistance* ; Diabetes Mellitus*/Diabetes Mellitus*/Diabetes Mellitus*/drug therapy ; Diabetes Mellitus*/Diabetes Mellitus*/Diabetes Mellitus*/epidemiology

  • Source: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Apr; Vol. 30 (4), pp. e14497. Date of Electronic Publication: 2023 Nov 06.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101473265 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Elucidating the glucose-lowering effect of the bile acid sequestrant sevelamer.

  • Authors : Nerild HH; Center for Clinical Metabolic Research, Copenhagen University Hospital - Herlev and Gentofte, Hellerup, Denmark.; Brønden A

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Insulin Resistance*; Humans

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Apr; Vol. 26 (4), pp. 1252-1263. Date of Electronic Publication: 2023 Dec 27.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Influence of sphingolipid enzymes on blood glucose levels, development of diabetes, and involvement of pericytes.

  • Authors : Buschard K; Department of Pathology, The Bartholin Institute, Rigshospitalet, Copenhagen Biocenter, Copenhagen, Denmark.; Josefsen K

Subjects: Islets of Langerhans* ; Diabetes Mellitus, Type 1* ; Insulin Resistance*/Insulin Resistance*/Insulin Resistance*/genetics

  • Source: Diabetes/metabolism research and reviews [Diabetes Metab Res Rev] 2024 Mar; Vol. 40 (3), pp. e3792.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883450 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Chronic intermittent hypoxia-induced oxidative stress activates TRB3 and phosphorylated JNK to mediate insulin resistance and cell apoptosis in the pancreas.

  • Authors : Zeng S; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.; Wang Y

Subjects: Cyclic N-Oxides* ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism ; Insulin Resistance*

  • Source: Clinical and experimental pharmacology & physiology [Clin Exp Pharmacol Physiol] 2024 Mar; Vol. 51 (3), pp. e13843.Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 0425076 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

A high-fat diet supplemented with medium-chain triglycerides ameliorates hepatic steatosis by reducing ceramide and diacylglycerol accumulation in mice.

  • Authors : Mourad S; Faculty of Pharmacy, Université de Montréal, Montréal, Quebec, Canada.; Montreal Diabetes Research Center, Montréal, Quebec, Canada.

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/drug therapy ; Diabetes Mellitus, Type 2* ; Insulins*

  • Source: Experimental physiology [Exp Physiol] 2024 Mar; Vol. 109 (3), pp. 350-364. Date of Electronic Publication: 2024 Jan 09.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9002940 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  12,010 results for ""INSULIN resistance""